Trilogy Capital’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DIAX
AAM
RJFSA
OA
RJA
Trilogy Capital's DIAX Position: Q4 2018 in Review
Trilogy Capital sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q4 2018, closing a stake of 846 shares — an estimated $17K sold.
Trilogy Capital first reported a position in DIAX in Q1 2018 and held it in 3 quarters. The position peaked at $17K in Q3 2018. 84 funds tracked by Wall St. Rank hold DIAX as of Q4 2018.
- Trilogy Capital reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q4 2018 after selling out during the quarter.
- Trilogy Capital sold 846 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q4 2018, an estimated $17K.
- Trilogy Capital first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q1 2018 and held it in 3 quarters.
- Trilogy Capital's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $17K in Q3 2018.
- 84 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q4 2018.
Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.